baclofen has been researched along with Laryngopharyngeal Reflux in 2 studies
Laryngopharyngeal Reflux: Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baclofen is an effective treatment option for patients with rumination syndrome, probably through its effect on LES pressure." | 2.87 | A Randomized Double-Blind, Placebo-Controlled, Cross-Over Study Using Baclofen in the Treatment of Rumination Syndrome. ( Broers, C; Pauwels, A; Rommel, N; Tack, J; Van Houtte, B; Vanuytsel, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pauwels, A | 1 |
| Broers, C | 1 |
| Van Houtte, B | 1 |
| Rommel, N | 1 |
| Vanuytsel, T | 1 |
| Tack, J | 1 |
| Lee, YC | 1 |
| Jung, AR | 1 |
| Kwon, OE | 1 |
| Kang, JW | 1 |
| Huh, JH | 1 |
| Eun, YG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Placebo-controlled, Cross-over Study Using Baclofen in the Treatment of Rumination Syndrome[NCT03113396] | Phase 4 | 20 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for baclofen and Laryngopharyngeal Reflux
| Article | Year |
|---|---|
A Randomized Double-Blind, Placebo-Controlled, Cross-Over Study Using Baclofen in the Treatment of Rumination Syndrome.
Topics: Adolescent; Adult; Baclofen; Cross-Over Studies; Double-Blind Method; Eructation; Esophageal Sphinct | 2018 |
1 other study available for baclofen and Laryngopharyngeal Reflux
| Article | Year |
|---|---|
The effect of baclofen combined with a proton pump inhibitor in patients with refractory laryngopharyngeal reflux: A prospective, open-label study in thirty-two patients.
Topics: Adult; Aged; Baclofen; Drug Therapy, Combination; Esophageal pH Monitoring; Female; Humans; Lansopra | 2019 |